Method For The Treatment Of Lung Cancer

  • Published: Dec 17, 2014
  • Earliest Priority: Jun 13 2013
  • Family: 3
  • Cited Works: 39
  • Cited by: 2
  • Cites: 7
  • Additional Info: Cited Works Published
Full-text?

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.

Abstract

The invention relates to the use of the amplification of SETDB1 gene in lung cancer patients as predictive marker for the determination of the response to a SETDB1 antagonist, particularly to a SETDB1-specific RNAi or to mithramycin. The invention relates to methods of treatment, methods for predicting the clinical response to a SETDB1 antagonist and methods for selecting a lung cancer patient for being treated with a SETDB1 antagonist based on the detection of SETDB1 gene amplification.


Claims

Information currently unavailable.

Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Dec 17, 2014
  • Application: Jun 13, 2013
    EP EP 13382224 A
  • Priority: Jun 13, 2013
    EP EP 13382224 A

Download Citation


Sign in to the Lens

Feedback